This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
The article by Margolis and Krause (The Journal, March 25, p. 1131) raises an important point that is not generally accorded sufficient recognition. Despite the frequent demonstration of the importance of phosphorus in tetany, little attention is paid to this element in the dietary management of clinical parathyroid tetany. Shelling and Goodman (The Journal, March 3, 1934, p. 669) pointed out that neglect of this factor may account for the occasional refractoriness of such patients to treatment with calcium and solution of parathyroid. There are several observations supporting the view that a relatively high phosphorus intake tends to exaggerate the metabolic defect characteristic of the hypoparathyroid state (Albright, Bauer, Claflin and Cockrill: J. Clin. Investigation11:411 [March] 1932. Robbins and Kydd, ibid. 14:220 [March] 1935. Allardyce: Am. J. Physiol.98:417 [Oct.] 1931). The fact is too frequently overlooked that milk, which is usually administered in
Cantarow A. MANAGEMENT OF TETANY. JAMA. 1939;112(17):1748. doi:10.1001/jama.1939.02800170094027
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: